Depression currently recognized by the medical profession is a common mental illness. The World Health Organization official said: Basically, the world's population every 20 people suffer from depression have a. Western medical profession that most people in their lifetime will suffer a period of depression. Symptoms of mild to severe but just. After suffering from depression if not treated in time some patients will have suicidal tendencies and thus brought ruin. So, depression is not a trivial matter but must be taken seriously as a mental illness. In 2002, the WHO depression as a disease is the world's fourth largest, and predicted it will rise in 2020 AD, the world's second largest disease, but the unexpected is just over a 6 to 7 years Depression is now the world's second largest increase in disease (second only to cardiovascular disease later), shows that depression around the world in recent years the incidence of speed.
Great potential in the domestic market
Comprehensive foreign sources, now about 340 million people worldwide suffer from depression. Abroad, antidepressant drugs and anxiety disorders together accounted for sales of 45% of CNS drug market share, antidepressants and therapeutic agent for schizophrenia, which together account for 80% of the world's psychiatric drugs. According to foreign reports, last year the total of antidepressants Sell Volume reached about 19 billion U.S. dollars, compared to 2002 net increase of about 90 billion U.S. dollars. Have been listed or are being developed in the antidepressant Drugs Species together as much as 50 ~ 60. The number of agents over the treatment of schizophrenia. According to foreign reports, eight best-selling antidepressant drugs antidepressant drugs worldwide sales total more than 80% of the market. This eight best-selling antidepressant globally are: fluoxetine, paroxetine, sertraline, fluvoxamine, venlafaxine, mirtazapine, duloxetine and amitriptyline so.
My depression the most conservative estimate the total number of 2,600 people. Over the past several decades, the medical profession in China in terms of depression diagnosis and treatment both behind the western countries, mainly because of diagnostic technology behind Western counterparts as well as domestic people, lack of knowledge about the disease, people even got Depression is also rarely take the initiative to hospital for treatment, so until today, the domestic treatment of depression, the proportion of patients is still only about 10%, far behind the world rate of treating patients with depression. Until the early 90s of last century, our clinical research staff really starting to focus on the treatment of depression. At the same time, China's antidepressant market has long been extremely slow rate of development. As far as domestic Medicine Commercial sector statistics, in 2001, antidepressant market in China is only one billion to 12 billion yuan. After 8 years and is the national antidepressant market is still only less than 50 billion yuan. In contrast, the U.S. company Eli Lilly's antidepressant Prozac (fluoxetine) had the highest year's global sales reached 2.8 billion U.S. dollars at one time as much, even though the drug has lost patent protection, imitation parts of the world who many, the market there are still 20 billion to 2.3 billion. The size of the market in China than the United States antidepressant fluoxetine fraction of global sales. Thus, despite the national incidence of depression is not lower than the countries of the world, China's anti-depressants there is a great market space. All in all, compared with other drug markets (particularly Antibiotic And the like), the antidepressant market in China is a market not yet fully developed.
Fluoxetine: Prozac face of the domestic drug
The drug in 1986, officially listed, enter the Chinese market in 1995 (trade name "Prozac"). It belongs to 5 - HT reuptake inhibitor drugs in the first only product. At that time in the international market has caused a sensation, then, with the other 5 - HT reuptake inhibitor antidepressant drugs onto the market, until after 2000, fluoxetine sales declining rapidly.
As China and the U.S. government had agreed?? Imitation of domestic enterprises in 1992 is a new drug is only allowed in domestic sales but not to overseas Export Therefore, in 1996, our total of five pharmaceutical companies allowed to manufacture bulk drugs and formulations of fluoxetine. But in fact the domestic production of fluoxetine in the small market share, mainly due to Lilly in the past 10 years, a large Chinese medicine hospitals in China have done a lot of the academic doctor Marketing Work, the majority of doctors on the benefits of Prozac have long been familiar, so domestic pharmaceutical companies produced fluoxetine prozac hard to compete with, so on the domestic drug sales lagged far behind Prozac.
Domestic pharmaceutical business sector, according to the statistics, although there are five manufacturers in China in the production of fluoxetine, but sales of domestic enterprises, fluoxetine, a total of less than Eli Lilly and Company sales in the Chinese market 1 / 4. Domestic sales of fluoxetine in terms of both well-known or not Prozac rivals. It is reported that Prozac sales mainly in Beijing, Tianjin, Shanghai and Guangzhou, large cities, mainly from domestic sales fluoxetine Midwest hospitals. Rural hospitals, smaller sales fluoxetine formulations (less than the national 1% of total sales fluoxetine) because the exact effect of fluoxetine in the treatment of depression, coupled with a large number of lower-priced generic products listed on the drug are expected in future China's market still has huge room for development. Currently, fluoxetine Prozac and domestic sales total about 1.2 billion to 15 billion yuan. I am a professional writer from China Textile and Leather, which contains a great deal of information about boys air jordan shoes , nike air womens trainers, welcome to visit!
Related Articles -
boys air jordan shoes, nike air womens trainers,
|
